Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
Metabolic dysfunction has an unfavorable influence on fibrosis regression in patients with CHC who achieve SVR after DAA treatment.
Authors
- Tom Ryu (ORCID: https://orcid.org/0000-0003-0027-0249)
- Hong Soo Kim (ORCID: https://orcid.org/0000-0003-3966-9302)
- Young Woon Chang (ORCID: https://orcid.org/0000-0001-7752-7618)
- Jae Young Jang (ORCID: https://orcid.org/0000-0001-5335-752X)
- Sae Hwan Lee (ORCID: https://orcid.org/0000-0001-8320-5914)
- Sang Gyune Kim (ORCID: https://orcid.org/0000-0001-8694-777X)
- Soung Won Jeong (ORCID: https://orcid.org/0000-0003-2855-6011)
- Jeong‐Ju Yoo (ORCID: https://orcid.org/0000-0002-7802-0381)
- Seung Up Kim (ORCID: https://orcid.org/0000-0002-9658-8050)
- Young Seok Kim (ORCID: https://orcid.org/0000-0002-7113-3623)
Institutions
- Yonsei University (KR)
- Soonchunhyang University (KR)
- Severance Hospital (KR)
- Gangnam Severance Hospital (KR)
Publication Details
- Journal
- Clinical and Molecular Hepatology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3350/cmh.2024.0904
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Research Foundation
- Soonchunhyang University
- National Research Foundation of Korea